Impact of a standardized heart failure order set on mortality, readmission, and quality and costs of care

International Journal for Quality in Health Care

Volumn 22, Issue 6, 2010, Pages 437-444

  Ballard, David J ^a   Ogola, Gerald ^a   Fleming, Neil S ^a   Stauffer, Brett D ^a   Leonard, Bradley M ^b   Khetan, Rainer ^c   Yancy, Clyde W ^d  

^a BAYLOR HEALTH CARE SYSTEM   (United States)

^b THE HEART HOSPITAL BAYLOR PLANO   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiovascular diseases; Hospital care; Mortality; Quality improvement; Quality indicators; Readmissions

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEART FAILURE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; COSTS AND COST ANALYSIS; EVIDENCE-BASED PRACTICE; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OBSERVATION; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT READMISSION; STANDARD OF CARE; TEXAS; UNITED STATES; YOUNG ADULT;

EID: 78649388160     PISSN: 13534505     EISSN: 14643677     Source Type: Journal    
DOI: 10.1093/intqhc/mzq051     Document Type: Article

References (35)

1. Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e21-181.
2. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
3. Hjalmarson A, Goldstein S, Fagerberg B et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000;283:1295-302.
4. Packer MCA, Charlon V, Cohen-Solal A et al. for the CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
5. Yusef S, Pitt B, Davis CE et al. for the SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
6. Fonarow GC, Abraham WT, Albert NM et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J 2004;148:43-51.
7. Fonarow GC. The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes. Rev Cardiovasc Med 2002;3 (Suppl. 3):S2-S10.
8. Ahmed A, Allman RM, DeLong JF et al. Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients. South Med J 2002;95:703-10.
9. Jencks SF, Huff ED, Cuerdon T. Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001. JAMA 2003;289:305-12.
10. Fonarow GC, Abraham WT, Albert NM et al. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch Intern Med 2007;167:1493-502.
11. Williams SC, Schmaltz SP, Morton DJ et al. Quality of care in U.S. hospitals as reflected by standardized measures, 2002-2004. N Engl J Med 2005;353:255-64.
12. Fonarow GC, Yancy CW, Heywood JT. Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. Arch Intern Med 2005;165:1469-77.
13. Vogeli C, Kang R, Landrum MB et al. Quality of care provided to individual patients in US hospitals: results from an analysis of national Hospital Quality Alliance data. Med Care 2009;47:591-9.
14. Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-235.
15. Ballard DJ, Ogola G, Fleming NS et al. The Impact of standardized order sets on quality and financial outcomes. In: Rockville (ed). Advances in Patient Safety: New Directions and Alternative Approaches. MD: Agency for Healthcare Research and Quality, 2008.
16. Fleming NS, Ogola G, Ballard DJ. Implementing a standardized order set for community acquired pneumonia: impact on mortality and cost. Jt Comm J Qual Saf 2009;35:414-21.
17. Joint Commission. National Hospital Quality Measures Specifications Manual. Available at http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/Current+NHQM+Manual.htm (24 September 2010, date last accessed).
18. National Technical Information Service. Social Security Administration's Death Master File. Available at http://www.ntis.gov/products/ssa-dmf.aspx (24 September 2010, date last accessed).
19. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ 2005;24:465-88.
20. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2009.
21. Glick HA, Doshi JA, Sonnad SS et al. Economic Evaluation in Clinical Trials. Oxford: Oxford University Press, 2007.
22. Meleskie J, Eby D. Adaptation and implementation of standardized order sets in a network of multi-hospital corporations in rural Ontario. Healthc Q 2009;12:78-83.
23. Reingold S, Kulstad E. Impact of human factor design on the use of order sets in the treatment of congestive heart failure. Acad Emerg Med 2007;14:1097-105.
24. Ranjan A, Tarigopula L, Srivastava RK et al. Effectiveness of the clinical pathway in the management of congestive heart failure. South Med J 2003;96:661-3.
25. Panella M, Marchisio S, Di Stanislao F. Reducing clinical variations with clinical pathways: do pathways work? Int J Qual Health Care 2003;15:509-21.
26. Panella M, Marchisio S, Gardini A et al. A cluster randomized controlled trial of a clinical pathway for hospital treatment of heart failure: study design and population. BMC Health Serv Res 2007;7:179.
27. Pettker CM, Funai EF. Clinical practice guidelines and scientific evidence. JAMA 2009;302:143; author reply 5-7.
28. Antman EM, Gibbons RJ. Clinical practice guidelines and scientific evidence. JAMA 2009;302:143-4; author reply 5-7.
29. Tricoci P, Allen JM, Kramer JM et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301:831-41.
30. Howlett JG. Performance feedback: a common thread in the process to provide optimal heart failure care. J Am Coll Cardiol 2009;53:423-5.
31. Neumann T, Biermann J, Erbel R et al. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 2009; 106:269-75.
32. Stewart S, Jenkins A, Buchan S et al. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002;4:361-71.
33. Lloyd-Jones DM, Larson MG, Leip EP et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002;106:3068-72.
34. Fonarow GC, Peterson ED. Heart failure performance measures and outcomes: real or illusory gains. JAMA 2009;302:792-4.
35. Brigham and Women's Hospital. Quality of Patient Care: Cardiovascular Center of Excellence - Heart Failure Quality Measures. Available at http://www.brighamandwomens.org/Quality/Cardiovascular/HF.aspx#6 (17 July 2009, date last accessed).